AAM Campaign Aims To Underline Value Of Generics
Social Media Campaign #4GRxANTED Raises Awareness With Videos And Donations
Amid an annual conference at which bolstering the off-patent industry’s reputation was a regular topic of discussion, the AAM has launched a new social media campaign that aims to raise awareness of generics, based around the idea of aspects of life that are taken for granted.
You may also be interested in...
Generics Bulletin Editor’s Picks For Q1 2023
Looking back over the first quarter of 2023, Generics Bulletin executive editor Dave Wallace picks out highlights from January to March that include the launch of the first US Humira biosimilar, new leadership at the top of some of the industry’s biggest players, annual results and strategy updates, and multiple major industry conferences – as well as the launch of our annual awards.
AAM Names Teva’s Baeder Chair As It Kicks Off Annual Meeting
Christine Baeder has become chair of the AAM’s board, with the Teva executive welcomed to role as the US industry association kicked off its annual Access! conference in Orlando.
UAE’s Bioventure Is Looking For Partners To Expand
Having recently added to its biosimilars alliance with Alvotech, Dubai-based Bioventure says it is looking to expand its international reach through further partnerships.